Technology | Thrombectomy Devices | July 25, 2019

Penumbra Launches Jet 7 Reperfusion Catheter With Xtra Flex Technology in U.S.

Catheter is used with Penumbra Engine in fully integrated Penumbra System for aspiration-based mechanical thrombectomy

Penumbra Launches Jet 7 Reperfusion Catheter With Xtra Flex Technology in U.S.

July 25, 2019 — Penumbra announced U.S. commercial availability of the Penumbra System’s most advanced technology, the Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting, July 22-25 in Miami. Penumbra Jet 7 with Xtra Flex technology is used with the Penumbra Engine in the fully integrated Penumbra System – an aspiration-based mechanical thrombectomy system that enables physicians to extract thrombus in acute ischemic stroke patients.

The Penumbra System is a fully integrated system designed specifically for mechanical thrombectomy by aspiration that first received 510(k) clearance by the U.S. Food & Drug Administration (FDA) in December 2007. It enables physicians to use aspiration, which acts like a minimally invasive “vacuum” inside the artery to remove stroke-causing blood clots from the brain safely and effectively. It is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusion.

The Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology is the latest advancement in the Penumbra System Jet – Engine family of products, which was launched last September.  As the eighth-generation reperfusion catheter for proximal large vessel occlusions, the catheter is designed for advanced trackability and navigation, and maintains the large 0.072-inch lumen.  Penumbra Jet 7 with Xtra Flex technology together with the power of the Penumbra Engine are designed to maximize thrombus removal force.

Initial clinical experience with the new technology was shared in the Industry Technology Luncheon Symposium by Donald F. Frei, M.D., director of neuro-interventional surgery, Swedish Medical Center, Englewood, Colo. 

For more information: www.penumbrainc.com

Related Content

News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
News | Cath Lab

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

Home September 21, 2021
Home
Feature | Cath Lab | By Aaron Detate and Lars Thording

In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...

Home September 14, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
News | Cath Lab

July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...

Home July 14, 2021
Home
Feature | Cath Lab | By Dave Fornell, Editor

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal ...

Home May 14, 2021
Home
News | Cath Lab

May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...

Home May 12, 2021
Home
Feature | Cath Lab | By Dave Fornell, Editor

April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from the ...

Home May 06, 2021
Home
Videos | Cath Lab

Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of ...

Home May 05, 2021
Home
News | Cath Lab

May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for stable ...

Home May 03, 2021
Home
Subscribe Now